No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
CRSP CRISPR Therapeutics
- 41.290
- -0.630-1.50%
Close Jan 8 16:00 ET
- 41.300
- +0.010+0.02%
Post 17:32 ET
3.52BMarket Cap-14.80P/E (TTM)
41.732High40.550Low981.51KVolume41.560Open41.920Pre Close40.40MTurnover1.17%Turnover RatioLossP/E (Static)85.35MShares91.10052wk High1.82P/B3.47BFloat Cap38.20052wk Low--Dividend TTM83.93MShs Float220.200Historical High--Div YieldTTM2.82%Amplitude11.630Historical Low41.162Avg Price1Lot Size
Post-Market
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
CRISPR Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
CRISPR Therapeutics AG (CRSP) Registers a Bigger Fall Than the Market: Important Facts to Note
Press Release: CRISPR Therapeutics Proposes New Appointment to the Board of Directors
BofA Securities Maintains CRISPR Therapeutics(CRSP.US) With Buy Rating, Cuts Target Price to $85
Cathie Wood's ARK Innovation ETF Couldn't Keep Up in 2024
CRISPR Therapeutics AG's (NASDAQ:CRSP) Recent 4.5% Pullback Adds to One-year Year Losses, Institutional Owners May Take Drastic Measures
Heat List
US
Overall
Symbol
Price
% Chg
No Data
